The listed company reported a 51% Year on Year leap in its consolidated net profit in the first nine months of 2020
By Staff Writer, Arab Finance
ArabFinance: GlaxoSmithKline's (GSK – Egypt) (BIOC) ordinary general assembly approved on May 26th the annual cash dividends of EGP 0.50 per share for 2020, according to the company's statement released on May 27th.
GSK-Egypt has intended to stabilize its operation in Egypt
GSK – Egypt stated the exit from the Egyptian market came in line with the parent company’s strategy to shrink its investment in emerging markets.
The listed company reported a 51% Year on Year leap in its consolidated net profit in the first nine months of 2020, recording EGP 101.39 million.
GSK Egypt, a member of the British pharmaceutical company Glaxo Group, is an Egypt-based company engaged in the manufacture, packaging, marketing, sale, and distribution of pharmaceutical products.
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
Get Zawya's daily newsletter for insightful and exclusive Middle East perspectives on business and finance. SUBSCRIBE NOW